ADVANZ PHARMA
Big PharmaADVANZ PHARMA is a major pharmaceutical company focused on Oncology, Neurology, Cardiovascular.
ADVANZ PHARMA's Key Drugs
ADVANZ PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ADVANZ PHARMA's Recent FDA Approvals
New NDA/BLA approvals for ADVANZ PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
ADVANZ PHARMA's Therapeutic Areas
ADVANZ PHARMA's approved drugs and pipeline span 5 therapeutic areas, led by Oncology and Neurology, across 0 biologic and 9 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ADVANZ PHARMA's Top Competitors
ADVANZ PHARMA's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Eli Lilly, and Novartis. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ADVANZ PHARMA Pipeline Snapshot
Active clinical trials for ADVANZ PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1953-01-26
- Latest
- 2025-11-17
- Applications
- 11